1. Phenotypic Differences in Dyt1 Between Ethnic Groups

   • Woong-Woo Lee
   • Tae-Beom Ahn
   • Beom Seok Jeon

   Invited Commentary 24 May 2012 Pages: 341 - 347

   

2. Epilepsy Surgery: Still Underutilized After All These Years

   • Carl W. Bazil

   Invited Commentary 24 May 2012 Pages: 348 - 349

3. Neuroinflammation and Non-motor Symptoms: The Dark Passenger of Parkinson’s Disease?

   • Christopher J. Barnum
   • Malú G. Tansey

   Movement Disorders (SA Factor, Section Editor) 12 May 2012 Pages: 350 - 358

   

4. Therapy in Huntington’s Disease: Where Are We?

   • Martha A. Nance

   Movement Disorders (SA Factor, Section Editor) 29 April 2012 Pages: 359 - 366

5. Urate in Parkinson’s Disease: More Than a Biomarker?

   • Xiqun Chen
   • Guanhui Wu
   • Michael A. Schwarzschild

   Movement Disorders (SA Factor, Section Editor) 12 May 2012 Pages: 367 - 375

   

6. Adenosine A2A Antagonists in Parkinson’s Disease: What’s Next?

   • Patrick Hickey
   • Mark Stacy

   Movement Disorders (SA Factor, Section Editor) 15 May 2012 Pages: 376 - 385

   

7. Anterocollis and Camptocormia in Parkinsonism: A Current Assessment

   • Gonzalo J. Revuelta

   Movement Disorders (SA Factor, Section Editor) 26 May 2012 Pages: 386 - 391

   

8. Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells

   • Jiali Pu
   • Houbo Jiang
   • Jian Feng

   Movement Disorders (SA Factor, Section Editor) 24 May 2012 Pages: 392 - 398

9. Botulinum Toxin for the Treatment of Movement Disorders

   • Mary Ann Thenganatt
   • Stanley Fahn

   Movement Disorders (SA Factor, Section Editor) 04 June 2012 Pages: 399 - 409

   

10. Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy

    • Robin C. C. Ryther
    • Michael Wong

    Epilepsy (CW Bazil, Section Editor) 29 April 2012 Pages: 410 - 418

    

11. Continuous EEG Monitoring in the Intensive Care Unit

    • Jeffrey D. Kennedy
    • Elizabeth E. Gerard

    Epilepsy (CW Bazil, Section Editor) 01 June 2012 Pages: 419 - 428

    

12. Continuous Electroencephalography Monitoring in Neonates

    • Renée A. Shellhaas

    Epilepsy (CW Bazil, Section Editor) 25 April 2012 Pages: 429 - 435

    

13. Recent Developments in Our Understanding of the Semiology and Treatment of Psychogenic Nonepileptic Seizures

    • Laura H. Goldstein
    • John D. C. Mellers

    Epilepsy (CW Bazil, Section Editor) 11 May 2012 Pages: 436 - 444

14. Genetics of Epilepsy and Relevance to Current Practice

    • Roberto Michelucci
    • Elena Pasini
    • Carlo Nobile

    Epilepsy (CW Bazil, Section Editor) 23 May 2012 Pages: 445 - 455

    

15. Critical Care of the Potential Organ Donor

    • Anna J. Dare
    • Adam S. Bartlett
    • John F. Fraser

    Critical Care (SA Mayer, Section Editor) 22 May 2012 Pages: 456 - 465

16. Sodium and Fluid Management in Acute Brain Injury

    • Wendy L. Wright

    Critical Care (SA Mayer, Section Editor) 24 May 2012 Pages: 466 - 473

    

17. Update on Multimodality Monitoring

    • Chad M. Miller

    Critical Care (SA Mayer, Section Editor) 22 April 2012 Pages: 474 - 480

    

18. Neurohospitalists: An Emerging Subspecialty

    • Ira Chang
    • Robert W. Pratt

    Critical Care (SA Mayer, Section Editor) 28 April 2012 Pages: 481 - 488